PRECISION BIOSCIENCES INC

DTIL Nasdaq CIK: 0001357874

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 302 EAST PETTIGREW STREET, DURHAM, NC, 27701
Mailing Address 302 EAST PETTIGREW STREET, DURHAM, NC, 27701
Phone 919-314-5512
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 17, 2026 View on SEC
10-K Annual financial report March 12, 2026 View on SEC
8-K Current report of material events March 12, 2026 View on SEC
4 Insider stock transaction report February 19, 2026 View on SEC
4 Insider stock transaction report February 19, 2026 View on SEC
4 Insider stock transaction report February 19, 2026 View on SEC
4 Insider stock transaction report February 19, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC

Annual Reports

10-K March 12, 2026
  • Strategic pivot to focus on proprietary ARCUS in vivo gene editing programs (HBV, DMD, PBGENE 3243) after discontinuing Cell Therapy operations.
  • Strong reliance on strategic partnerships (Novartis, Imugene, TG Therapeutics) for funding, validation, and commercialization.
View Analysis

Insider Trading

SELL 7 insiders 11 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.